Drawing for UBIQSOME

USPTO serial 79455054

UBIQSOME

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
Law office

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with UBIQSOME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Chemicals for pharmaceutical and medical purposes, namely for treating diseases of the cardiovascular system, diseases of the gastrointestinal system, diseases of the respiratory system, diseases of the immune and endocrine system and for treating chronic inflammatory diseases; nutritional supplements and medicated foodstuffs for use as antioxidants and energy boostersACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2026MAFRAPPLICATION FILING RECEIPT MAILED
Aug 12, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 11, 2026LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 23, 2026SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance